Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04383730
What this trial is testing

Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)

Who this might be right for
Critically IllnessSedationInvasive Mechanical Ventilation+1 more
University Hospital, Clermont-Ferrand 203
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Testing effectiveness (Phase 2)Study completedNCT04409509
What this trial is testing

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
CSL Behring 124
Not applicableUnknownNCT04443712
What this trial is testing

Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)

Who this might be right for
Coronavirus Disease 2019 (COVID19)
Samia Girgis 1,900
Large-scale testing (Phase 3)Ended earlyNCT04539275
What this trial is testing

VA CoronavirUs Research and Efficacy Studies-1

Who this might be right for
COVID-19
VA Office of Research and Development 75
Testing effectiveness (Phase 2)Study completedNCT04359654
What this trial is testing

Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 (Coronavirus Disease 2019)Hypoxia
University College, London 41
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Not applicableStudy completedNCT04424017
What this trial is testing

Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

Who this might be right for
COVIDCorona Virus Infection
Egyptian Center for Research and Regenerative Medicine 1,546
Not applicableUnknownNCT04273763
What this trial is testing

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Who this might be right for
Novel Coronavirus Pneumonia2019-nCoV
Second Affiliated Hospital of Wenzhou Medical University 18
Testing effectiveness (Phase 2)Ended earlyNCT04391309
What this trial is testing

COVID-19 and Anti-CD14 Treatment Trial

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT04838834
What this trial is testing

Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children

Who this might be right for
COVID-19SARS-CoV-2Inflammatory Bowel Diseases
Connecticut Children's Medical Center 472
Testing effectiveness (Phase 2)Ended earlyNCT04788459
What this trial is testing

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Who this might be right for
COVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation
Takis 68
Post-approval studies (Phase 4)WithdrawnNCT04565392
What this trial is testing

Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)

Who this might be right for
Covid19
drpykessupplements.com
Not applicableUnknownNCT05539664
What this trial is testing

Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of COVID-19 Positive Patients

Who this might be right for
Covid19Hydrogen-oxygen GasAMS-H-03
Ruijin Hospital 188
Testing effectiveness (Phase 2)UnknownNCT06042764
What this trial is testing

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Who this might be right for
Infection of Upper Respiratory Tract Caused by 2019-nCoV
Sinovac Life Sciences Co., Ltd. 150
Not applicableWithdrawnNCT04409184
What this trial is testing

Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection

Who this might be right for
COVIDSars-CoV2
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT05077332
What this trial is testing

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences 4
Not applicableUnknownNCT04388631
What this trial is testing

Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.

Who this might be right for
Coronavirus Disease 2019
Tongji Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT05081388
What this trial is testing

COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Regeneron Pharmaceuticals 25
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Next Page